A Real-World Study of JT001 for COVID-19

A Study to Evaluate the Efficacy and Safety of DXP604 in Patients With Mild to Moderate COVID-19

NCT05381519 ·Status: UNKNOWN ·Phase: PHASE2

JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects

NCT04780321 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901 or MVC-COV1901(Beta) Against COVID-19

NCT05216601 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1a Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19

NCT05394012 ·Status: UNKNOWN ·Phase: PHASE1

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population

NCT04649021 ·Status: COMPLETED ·Phase: PHASE2

Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)

NCT04530656 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects

NCT04523571 ·Status: COMPLETED ·Phase: PHASE1

A Safety and Tolerability Study of BDB-001 in Mild, Moderate COVID-19 Patients

NCT05075304 ·Status: TERMINATED ·Phase: PHASE1

A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Adults Aged 18 -59 Years.

NCT05354089 ·Status: UNKNOWN ·Phase: PHASE1

A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Participants Aged 18 Years or More

NCT05439824 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Chinese Healthy Adults

NCT05275660 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Tolerability of MY-586 COVID-19 Neutralizing Antibody Nasal Spray in Healthy Subjects

NCT05977101 ·Status: UNKNOWN ·Phase: NA

A Phase I/II Study to Evaluate a SARS-CoV-2 mRNA Vaccine in Healthy Adults

NCT05903118 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Safety, Tolerability, and Efficacy Study of IBI314 in Ambulatory Patients With COVID-19

NCT05162365 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Real-world Study to Evaluate the Safety and Immunogenicity of a Third-dose Booster After Two Doses of an Inactivated COVID-19 Vaccine

NCT05493917 ·Status: UNKNOWN

A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19

NCT04487210 ·Status: COMPLETED ·Phase: PHASE1

A PhaseⅡ Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine

NCT06113731 ·Status: RECRUITING ·Phase: PHASE2

Immunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above

NCT05664932 ·Status: UNKNOWN ·Phase: PHASE3

Safety, Reactogenicity and Immunogenicity Study of ReCOV

NCT04818801 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Clinical Trial of SARS-CoV-2 mRNA Vaccine in China

NCT05364047 ·Status: UNKNOWN ·Phase: PHASE1

A Phase 1b Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19

NCT05396573 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19

NCT04940182 ·Status: COMPLETED ·Phase: PHASE3

A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age

NCT05995275 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults

NCT04313127 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of JS016 in Patients With SARS-CoV-2 Infection (COVID-19)

NCT04931238 ·Status: UNKNOWN ·Phase: PHASE2